Druggability Technologies USA Announces Appointment of John E. Friend II, M.D. as Chief Medical Officer

NEW YORK, Dec. 6 (Korea Bizwire) — Druggability Technologies USA today announced that Dr.  John E. Friend II has been named as Chief Medical Officer. Druggability Technologies USA has been engaged by Druggability Technologies Holding (DRGT) to assist with the clinical development of all human trials for DRGT. DRGT is a specialty pharmaceutical company that [...]